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OBJECTIVE — That type 2 diabetes is associated with the metabolic syndrome is known.
However, information is lacking regarding the long-term and adverse changes of metabolic
syndrome variables in the development of type 2 diabetes from childhood to adulthood.
RESEARCH DESIGN AND METHODS — Observations were examined, retrospec-
tively, in a community-based cohort of normoglycemic (n  1,838), pre-diabetic (n  90), and
type 2 diabetic (n  60) subjects followed serially for cardiovascular risk factors during child-
hood (4–11 years), adolescence (12–18 years), and adulthood (19–44 years).
RESULTS — Diabetic subjects versus normoglycemic subjects had signiﬁcantly higher levels
of subscapular skinfold, BMI, triglycerides, glucose, insulin, and homeostasis model assessment
of insulin resistance and lower levels of HDL cholesterol beginning in childhood and higher
levels of mean arterial pressure (MAP) in adolescence and adulthood. In a multivariate model
including BMI, MAP, HDL cholesterol, LDL cholesterol, triglycerides, glucose, and insulin,
adjusted for age, age
2, race, sex, and race  sex interaction, adverse changes in glucose and LDL
cholesterol were independently associated with pre-diabetic subjects, whereas adverse changes
in BMI, glucose, and HDL cholesterol were associated with diabetic subjects. As young adults,
pre-diabetic and diabetic groups displayed a signiﬁcantly higher prevalence of obesity, hyper-
tension, dyslipidemia, hyperinsulinemia, and metabolic syndrome.
CONCLUSIONS — These ﬁndings indicate that adverse levels of risk variables of metabolic
syndrome, adiposity, and measures of glucose homeostasis accelerating since childhood char-
acterize the early natural history of type 2 diabetes and underscore the importance of early
prevention and intervention on risk factors beginning in childhood.
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M
ore than 19 million people have
type 2 diabetes and another 54
million individuals show im-
paired fasting glucose as adults, which
may represent a pre-diabetic state (1).
This carbohydrate-insulin imbalance be-
comes one of the most common causes of
death in the U.S. (2). It is also widely rec-
ognized that type 2 diabetes increases the
riskforcardiovascularmorbidityandpre-
mature death (3). On the basis of the pro-
gressive global epidemic of obesity, it is
expected that the worldwide prevalence
of type 2 diabetes will rise by 50% to
360 million people over the next 30
years (4). Because a much larger popula-
tion can be classiﬁed as pre-diabetic, the
additionalriskofcardiovascularmortality
becomes enormous (5).
As for type 2 diabetes, the pathogen-
esis of pre-diabetes is linked to a relative
insulindeﬁciencyand/ortissueinsulinre-
sistance associated with elevated blood
glucose levels, despite secondary hyper-
insulinemia (6). According to the classiﬁ-
cation of the American Diabetes
Association (7), pre-diabetes and type 2
diabetes represent the two categories of
impaired glucose regulation and are asso-
ciated with a constellation of disorders
characteristic of the metabolic syndrome
(8,9). However, most studies have been
performed on single, baseline measure-
ments at middle and older ages (10,11).
Information is lacking on long-term, lon-
gitudinal, and progressive changes of the
risk variables of the metabolic syndrome
from childhood to younger adulthood.
This study observed changes over a 21-
year period beginning in childhood.
RESEARCH DESIGN AND
METHODS— The Bogalusa Heart
Study is being conducted in the semiru-
ral, biracial (65% white and 35% black)
community of Bogalusa, Louisiana. Be-
tween 1976 and 1994, six cross-sectional
studies of school-aged children were con-
ducted. In addition, eight cross-sectional
surveys were conducted between 1978
and 2002 using young adults who had
been examined previously as children. A
detailed description of the study design,
participation, and protocols was pub-
lished elsewhere (12). This panel design,
based on repeated cross-sectional exami-
nations conducted approximately every
3–4 years, resulted in serial observations
from childhood to young adulthood, al-
lowing longitudinal analyses. The partic-
ipant rate was 80% for the children and
60% for the adult cohort.
Subjects from six cross-sectional
studies of children who participated in at
least one of the 14 cross-sectional surveys
of children and adults were eligible for
thisretrospectivecohortstudy.Ofthese,a
total of 1,988 fasting subjects (68% white
and43%male)wereselectedfromthelast
three surveys of adults from 1995–2002.
At the baseline examination, the children
with a history of treatment of diabetes or
those who had a fasting glucose level 7
mmol/l were excluded. At the initial
screening, the mean  SD age was
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most recent screening, the age was
32.0  6.5 years (19–44). The mean
follow-up interval was 21 years. The
number of screenings and observations
between childhood and adulthood
ranged from 2 to 9. In all, 91% of sub-
jects were screened 3 times and 63%
werescreened4–6times,withatotalof
9,232 sets of observations.
On the basis of the data at the last
survey, adult subjects were classiﬁed as
normoglycemic, pre-diabetic, or diabetic
accordingtotheAmericanDiabetesAsso-
ciation criteria (7). Individuals were con-
sidered normoglycemic (n  1,838) if
they had a fasting glucose level 5.6
mmol/l,pre-diabetic(n90)iftheirfast-
ing glucose level was between 5.6 and 6.9
mmol/l, or diabetic (n  60) if 1) their
fasting glucose level was 7 mmol/l or 2)
they had a history of treatment of diabe-
tes. The institutional review board ap-
proved consent forms used for these
surveys, and informed consent was ob-
tained from adult study participants and
from parents or guardians of children.
General examination
Identical protocols were used by trained
examiners,nurses,andtechniciansacross
all surveys; procedures for general exam-
ination were reported previously (13). In
brief, subjects were instructed to fast for
12 h before the screening, with compli-
ance ascertained by an interview on the
day of examination. Serum samples were
obtained from antecubital venous blood
and kept at 4°C until analysis the follow-
ing day. Each screening day, on a random
10% subsample, a second blood sample
was collected, labeled, and analyzed in a
blind fashion to estimate the measure-
ment error. Information on personal
health and medication history was ob-
tained by questionnaires. All measure-
ments were made in replicate, and mean
values were used. In the longitudinal
analysis, BMI (weight in kilograms di-
vided by the square of height in meters)
wasusedasameasureofoveralladiposity
and subscapular skinfold measured with
Langeskinfoldcaliperswasusedfortrun-
cal fatness. Young adults were considered
obese if their BMI was 30 kg/m
2. Blood
pressure measurements were obtained on
the right arm with the subjects in a re-
laxed, sitting position. Systolic and dia-
stolic blood pressures were recorded at
theﬁrstandﬁfthKorotkoffphasesusinga
mercury sphygmomanometer. Blood
pressure levels were reported as the mean
of six replicate readings, with three taken
by each of two randomly assigned and
trained observers. Mean arterial pressure
(MAP), calculated as diastolic blood pres-
sure plus one-third pulse pressure, was
used in the analysis.
Laboratory analyses
From 1973 to 1986, cholesterol and trig-
lycerides levels were measured using
chemical procedures on a Autoanalyzer II
(Technicon) according to the Laboratory
Manual of the Lipid Research Clinics Pro-
gram. These variables were determined
by enzymatic procedures on a VP instru-
ment (Abbott) between 1987 and 1996
and on the Hitachi 902 Automatic Ana-
lyzer (Roche) afterward. Both chemical
andenzymaticproceduresmettheperfor-
mance requirements of the Lipid Stan-
dardization Program of the Centers for
Disease Control and Prevention, which
routinelymonitoredtheprecisionandac-
curacy of cholesterol, triglyceride, and
HDL cholesterol measurements since the
beginningofthisstudy.Measurementson
the quality-control samples assigned by
the agency showed no consistent bias
over time within or between surveys. Se-
rum lipoprotein cholesterol levels were
analyzed by using a combination of
heparin-calcium precipitation and agar-
agarose gel electrophoresis procedures
(14). The intraclass correlation coefﬁ-
cients between the blind duplicate (10%
random sample) values ranged from 0.86
to 0.98 for HDL cholesterol, from 0.86 to
0.98 for LDL cholesterol, and from 0.88
to 0.99 for triglycerides. On the basis of
the National Cholesterol Education Pro-
gramAdultTreatmentPanelIIIguidelines
(15),adultsubjectswereclassiﬁedashav-
ing dyslipidemia if they had high LDL
cholesterol (4.14 mmol/l), high triglyc-
erides (2.26 mmol/l), or low HDL cho-
lesterol (1.03 mmol/l) or if they were
takingmedicationfordyslipidemiaandas
having metabolic syndrome if they had at
leastthreeriskfactorsconsistentwiththat
diagnosis.
From 1976 to 1991, plasma glucose
was measured by a glucose oxidase
method using a glucose analyzer (Beck-
man). Since then, it has been measured
enzymatically as part of a multichemistry
(SMA20) proﬁle. Plasma immunoreac-
tive insulin levels were measured by a
commercial radioimmunoassay kit (Ph-
adebas; Pharmacia). The intraclass cor-
relation coefﬁcients between the blind
duplicatevaluesrangedfrom0.94to0.98
for insulin and from 0.86 to 0.98 for glu-
cose. Hyperinsulinemia was arbitrarily
deﬁned as a fasting value 108 pmol/l, a
value considered indicative of insulin re-
sistance in normoglycemic subjects (16).
In addition, an index of insulin resistance
was calculated according to the ho-
meostasis model assessment for insulin
resistance formula: HOMA-IR  [insulin
(microunitspermilliliter)glucose(mil-
limoles per liter)/22.5]. This model was
considered useful for assessing insulin re-
sistance in epidemiological studies.
Statistical analysis
All of the statistical analyses were per-
formed with SAS (version 9.1; SAS Insti-
tute, Cary, NC). In the analyses, the race-
sex groups were combined to increase
statistical power and to simplify the pre-
sentation. Continuous variables were
tested for normality using a Kolmogorov-
Smirnovtest.Valuesfortriglycerides,glu-
cose, and insulin and HOMA-IR variables
used in the analyses were log transformed
to improve normality as necessary. Mean
levels of risk variables in 4- to 11-, 12- to
18-, and 19-year-old age-groups corre-
sponding with the preadolescence, ado-
lescence, and adulthood period were
compared by their diabetes status in
adulthood (normoglycemic versus pre-
diabetic, normoglycemic versus diabetic,
andpre-diabeticversusdiabetic).Asingle
measurement per subject was used to cal-
culate mean levels of risk variable within
age-groups. General linear models were
used to examine impaired glucose regula-
tion differences in risk factor variables,
adjusted for age, race, and sex. By using
data from the last survey in adulthood,
signiﬁcantdifferencesintheprevalenceof
pre-diabetes and diabetes by race and sex
and metabolic syndrome and its related
cardiovascularriskfactorsbydiabetessta-
tus were tested by Pearson’s 
2 test.
Multivariate analyses (generalized es-
timation equation method) were used to
determine which longitudinal changes in
risk variables since childhood predicted
adultdiabetesstatus.Themodelincluded
BMI, MAP, HDL cholesterol, LDL choles-
terol, triglycerides, glucose, and insulin,
adjusted for age, age
2, race, sex, and sex-
by-race interaction, as applicable. Non-
signiﬁcant terms (P  0.05) were re-
moved from the model by backward
stepwise procedure.
RESULTS— Mean levels of anthropo-
metric, hemodynamic, and metabolic
variables at baseline are presented in Ta-
ble 1 by diabetes status. The pre-diabetic
Nguyen and Associates
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cholesterol, and glucose than the normo-
glycemic group. With the exceptions of
diastolic blood pressure and LDL choles-
terol, the diabetic group versus normo-
glycemic group showed signiﬁcantly
higher age, subscapular skinfold, BMI,
systolic blood pressure, MAP, triglycer-
ides, glucose, insulin, and HOMA-IR and
lower HDL cholesterol. Compared with
the pre-diabetic group, diabetic subjects
hadsigniﬁcantlyhighersubscapularskin-
fold, BMI, and triglycerides and lower
HDL cholesterol.
The prevalence of metabolic syn-
drome and its related cardiovascular risk
factors in adulthood at the last survey is
showninTable1bydiabetesstatus.Com-
pared with the normoglycemic group,
obesity in terms of excess generalized ad-
iposity (BMI), hypertension, dyslipide-
mia, and hyperinsulinemia (indicative of
insulin resistance), and metabolic syn-
drome were signiﬁcantly more prevalent
amongthepre-diabetic(exceptHDLcho-
lesterol) and diabetic (except LDL choles-
terol) groups. Compared with the pre-
diabetic group, high risk levels of HDL
cholesterol were more prevalent among
thediabeticgroup.Theoverallprevalence
of the metabolic syndrome was 18.4% in
the total sample (data not shown).
Mean levels of variables of metabolic
syndrome in childhood (4–11 years), ad-
olescence (12–18 years), and adulthood
(19–44 years) are shown in Fig. 1 by di-
abetes status in adulthood. A single mea-
surement per subject was used in each
age-group. Comparisons were made after
adjustment for age, race, and sex. The
pre-diabeticgroupversusnormoglycemic
individuals showed higher levels of glu-
coseandsubscapularskinfoldfromchild-
hood through adulthood; higher levels of
LDL cholesterol, insulin, and HOMA-IR
inadolescenceandadulthood;andhigher
levels of BMI, MAP, and triglycerides in
adulthood. On the other hand, the dia-
betic group versus the normoglycemic
group had higher levels of subscapular
skinfold, BMI, triglycerides, glucose, in-
sulin, and HOMA-IR and lower levels of
HDL cholesterol from childhood through
adulthood and higher levels of MAP in
adolescence and adulthood. In addition,
the diabetic group versus the pre-diabetic
group had higher levels of subscapular
skinfold in adolescence and adulthood,
higherBMIinadolescence,andlowerlev-
els of HDL cholesterol and LDL choles-
terol and higher levels of glucose and
HOMA-IR in adulthood.
As shown in Supplementary Fig. 1 of
the online appendix (available at http://
dx.doi.org/10.2337/dc08-0898), white
male subjects had a signiﬁcantly higher
prevalence of pre-diabetes than white fe-
male subjects. With respect to diabetes,
white male versus white female subjects
andblackfemaleversuswhitefemalesub-
jects had a signiﬁcantly greater preva-
lence. Male versus female subjects with
pre-diabetes and black versus white sub-
jects with diabetes had a signiﬁcantly
higher prevalence; overall prevalences of
pre-diabetes and diabetes were 4.5 and
3.0% in the total sample, respectively
(data not shown).
Longitudinal rates of change in risk
variables of metabolic syndrome by dia-
betes status were observed (Supplemen-
tary Table 1 of the online appendix).
Compared with the normoglycemic
group,theratesofincreaseinsubscapular
skinfold, BMI, triglycerides, glucose, in-
sulin, and HOMA-IR were signiﬁcantly
higher among the pre-diabetic and dia-
betic groups and the rates of increase in
diastolic blood pressure and MAP were
signiﬁcantly higher among the diabetic
group.
Independent relationships between
adverse longitudinal changes in risk vari-
ables since childhood and adult pre-
diabetes and diabetes conditions were
determined in the multivariate models,
presented in Table 2. Adverse changes in
LDL cholesterol and glucose were inde-
pendently associated with pre-diabetes
status and adverse changes in BMI, HDL
cholesterol,andglucosewithdiabetessta-
tus. When HOMA-IR index, instead of
glucose and insulin, was included in the
models, HOMA-IR index, LDL choles-
terol, and glucose were signiﬁcant inde-
pendent predictors in the pre-diabetic
groupandHOMA-IR,BMI,andHDLcho-
lesterol were predictors in the diabetic
group; further, alternate multivariate
analyses using subscapular skinfold, in-
stead of BMI, gave essentially identical re-
sults (data not shown).
CONCLUSIONS — These observa-
tions explore the natural history of im-
paired glucose regulation and diabetes
status in a community-based population
ofchildrenfreefromaselectionbiasmon-
Table 1—Levels at baseline in childhood and prevalence at last survey in adulthood of risk
variables related to metabolic syndrome by adult diabetes status: the Bogalusa Heart Study
Variable Normoglycemia Pre-diabetes Diabetes
n 1,838 90 60
At baseline
Age (years)* 10.8  0.1 12.4  0.4** 12.3  0.5¶
Subscapular skinfold (mm)† 12.6  0.2 14.2  0.7 17.0  1.1††‡‡
BMI (kg/m
2)† 18.3  0.1 19.5  0.4 22.2  0.8††
Systolic blood pressure (mmHg)† 100.8  0.3 105.0  1.2 107.5  1.7**
Diastolic blood pressure (mmHg)† 61.8  0.2 64.5  1.2 65.0  1.3
MAP (mmHg)† 74.8  0.2 78.0  1.1 79.2  1.3
LDL cholesterol (mmol/l)† 2.27  0.02 2.36  0.07 2.32  0.10
HDL cholesterol (mmol/l)† 1.60  0.01 1.62  0.06 1.38  0.06**§§
Triglycerides (mmol/l)† 0.73  0.01 0.78  0.04 0.90  0.05††‡‡
Glucose (mmol/l)† 4.7  0.01 5.0  0.1** 5.1  0.1††
Insulin (pmol/l)† 53.6  1.6 76.7  15.9 98.1  17.4¶
HOMA-IR† 1.8  0.1 2.8  0.6 3.8  0.8**
At last survey
Obesity: BMI 30 kg/m
2 32.9‡ 60.0†† 75.0††
Hypertension: 140/90 or
treatment 10.6 23.3** 38.3††
Dyslipidemia
HDL cholesterol 1.03 mmol/l 24.8 31.1 47.5††‡‡
LDL cholesterol 4.14 mmol/l 11.9 24.4** 18.6
Triglycerides 2.26 mmol/l 10.1 25.6†† 32.2††
Hyperinsulinemia: 108 pmol/l 13.6 55.1†† 51.7††
Metabolic syndrome§ 14.1 68.9†† 78.0††
Data are means  SD or %. *P values were adjusted for race and sex. †P values were adjusted for age, race,
and sex. ‡Prevalence (%) at last survey. §Deﬁned by the National Cholesterol Education Program Adult
Treatment Panel III. Different from normoglycemia: P  0.05; ¶P  0.01; **P  0.001; ††P  0.0001.
Different from pre-diabetes: ‡‡P  0.05; §§P  0.01; P  0.0001.
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from childhood to adulthood by adult diabetes status: the Bogalusa Heart Study.
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years. Data linked the conditions of pre-
diabetes and type 2 diabetes in young
adults with concurrent longitudinal
changesinsomemetabolicsyndromerisk
variables from childhood to young adult-
hood. The present population study
shows that among the metabolic syn-
drome risk variables, in a comparison
with normoglycemic subjects, glucose
was consistently higher from childhood
through adulthood in both pre-diabetic
anddiabeticsubjects;LDLcholesterol,in-
sulin, and HOMA-IR were higher in pre-
diabetic subjects since adolescence; and
obesity, triglycerides, insulin, and
HOMA-IR were higher and HDL choles-
terolwaslowerindiabeticsubjectsbegin-
ning in childhood. In terms of adverse
longitudinal changes from childhood to
adulthood, LDL cholesterol and glucose
were independently related with pre-
diabetic status, whereas obesity, HDL
cholesterol, and glucose were related to
diabetic status.
Inthecurrentstudy,theprevalenceof
both pre-diabetes, which may represent
an impaired fasting glucose state, and di-
abetes was lower than that found previ-
ously (1,8,10). This difference can be
explained by the lower average age of our
cohort. The observed differences of sex
(malefemale)inthepre-diabeticgroup
(1,8,10) and race (black  white) in the
diabetic group (1) in the study cohort are
inagreementwiththeearlierreports.Fur-
ther, compared with other race-sex
groups,pre-diabetes(10)anddiabetes(1)
were less prevalent among white females.
It is of interest that levels of obesity
were higher beginning in childhood,
changed adversely through adulthood,
and related independently with diabetes
in adulthood. This observation is consis-
tentwiththeknowntrackingofriskfactor
variables over time and especially of
childhood obesity in predicting adult-
hood obesity (17). The persistent eleva-
tion of obesity has inﬂuenced the onset of
type2diabetesoccurringatayoungerage
(17,18). With respect to the longitudinal
changesinthispresentstudycohort,obe-
sity was the most consistent predictor of
adverse changes leading to diabetes, re-
gardless of age, race, or sex. A number of
studies have shown baseline obesity as an
independent and modiﬁable risk factor
for type 2 diabetes (18,19). Although of
different populations, studies showed
obesityinyoungchildrenandadolescents
asastrongpredictorofsubsequentdiabe-
tes(17,18).Suchobservationssuggestthe
molecular mechanisms by which obesity
plays a part in glucose intolerance are
complexandincludeacombinationofge-
netic factors and mechanisms in which
skeletal myocytes and central adipocytes
play a role (19).
This study demonstrates that both
pre-diabetic and diabetic groups dis-
played excess basal glucose, insulin, and
HOMA-IR index values at least by adoles-
cence. Of note, the diabetic group dis-
played a persistent elevation of glucose
from childhood through adulthood. Fur-
ther, glucose, but not insulin, along with
lipid and obesity (in the diabetic group)
variables were the independent predic-
tors of adverse longitudinal changes of
impaired glucose regulation. Of interest,
bloodpressurewasnotindependentlyas-
sociated in the models, which is consis-
tent with an earlier study in childhood
and adolescence (18). Although blood
pressure and insulin were individually
predictors of diabetes, they were not in-
dependently correlated once obesity, glu-
cose, and lipid variables were introduced
in the multivariate analyses (18).
The deterioration in glucose levels to
pre-diabetes or diabetes that, after a rela-
tively stable period, occurs as a rapid, in-
cremental increase accompanied by a
decline in insulin sensitivity has been
noted (20). In the current cohort study,
both showed progressively increased glu-
cose levels beginning in early life, before
the onset of impaired glucose regulation
status,suggestingthatevensmallchanges
in glucose levels may be a marker of al-
tered carbohydrate-insulin imbalance.
In the present study, adverse changes
in LDL cholesterol and HDL cholesterol
wereindependentlycorrelatedamongthe
pre-diabetic and diabetic groups. Of
relevance to this present ﬁnding, HDL
cholesterol was demonstrated as an inde-
pendent modiﬁable predictor of diabetes
in childhood and adolescence in Pima In-
dians(18).Individualswithdiabetesusu-
ally have increased triglycerides and
decreasedHDLcholesterolresultingfrom
the release of fatty acids from adipose tis-
sue, the elevation of delivery of free fatty
acids to the liver, and the hepatic synthe-
sis of VLDLs (21). This abnormal lipid
proﬁle is characterized by modestly ele-
vated LDL cholesterol and high triglycer-
ides levels with a markedly increased
cardiovascular risk among diabetic pa-
tients (22).
Perhaps most important is the obser-
vation that young adults with pre-
diabetes and diabetes showed an
increased prevalence of metabolic syn-
drome and its multiple risk factors. The
observed overall prevalence of metabolic
syndrome is in agreement with an earlier
report (23). Also, metabolic syndrome
status was more prevalent in the pre-
diabetic and diabetic groups, as might be
expected and is consistent with previous
ﬁndings (11). A pre-diabetic status re-
ﬂects an atherogenic proﬁle of metabolic
syndrome risk variables long before an
overt clinical macrovascular event (24).
Further,thesemultipleriskfactorsrelated
to autopsy ﬁndings of coronary athero-
sclerosis that we studied in our young in-
dividuals, evidence of “silent,” subclinical
disease that evolves from childhood.
As limitations, this study lacks post-
challenge glucose and in vivo insulin ac-
tionandsecretion.Instead,anestablished
Table 2—Adverse longitudinal changes in risk variables since childhood as independent correlates of adult diabetes status in the study cohort:
the Bogalusa Heart Study
Independent variable
Pre-diabetes vs. normoglycemia Diabetes vs. normoglycemia
* 95% CI P * 95% CI P
BMI — — — 0.09 0.06–0.12 0.0001
HDL cholesterol — — — 	0.60 	1.11 to 	0.10 0.05
LDL cholesterol 0.37 0.18–0.55 0.0001 — — —
Glucose 1.87 1.64–2.11 0.0001 1.76 1.49–2.03 0.0001
*Generalized equation estimation method regression coefﬁcient adjusted for age, age
2, race, sex, and the race  sex interaction, as applicable. Model includes BMI,
MAP, LDL cholesterol, HDL cholesterol, triglycerides, glucose, and insulin.
Longitudinal trait for diabetes since childhood
2048 DIABETES CARE, VOLUME 31, NUMBER 10, OCTOBER 2008simple surrogate measure HOMA-IR in-
dex applicable to population studies was
used. Also, because of the lack of dietary
intakedata,thisstudydidnotaddressthe
role of diet in the regulation of glucose
homeostasis and related risk of obesity,
cardiovascular disease, and type 2 diabe-
tes (25). The fasting status was based on
self-report.
In summary, these ﬁndings indicate
thatadverselevelsofriskvariablesofmet-
abolicsyndrome,adiposity,andmeasures
of glucose homeostasis in particular, and
their accelerated rates of change since
childhood, characterizes the early natural
history of carbohydrate-insulin imbal-
ance.Thecurrentﬁndingsreinforceapri-
mary role for early prevention of and
intervention for these risk factors, espe-
cially obesity, beginning in childhood.
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